NEUROPACE, INC. Payments of Debt Issuance Costs
NEUROPACE, INC. (NPCE) reported Payments of Debt Issuance Costs of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2022-03-10
- NEUROPACE, INC. payments of debt issuance costs for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- NEUROPACE, INC. payments of debt issuance costs for the quarter ending 2020-12-31 was $96.00K.
- NEUROPACE, INC. payments of debt issuance costs for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- NEUROPACE, INC. payments of debt issuance costs for fiscal 2020 was $950.00K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $0.00 10-K · filed 2022-03-10 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 | ||
| 2020-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $950.00K 10-K · filed 2022-03-10 | |
| 2020-09-30 | $854.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |